BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 30, 2019
View Archived Issues
Pembrolizumab treatment in patients with progressive multifocal leukoencephalopathy
Read More
Proteomics enriches genomics for colon cancer understanding
Read More
Lilly presents LY-3410738, a new IDH1 inhibitor with potential for treating cancer
Read More
Characterization of OG-716, a novel lantibiotic for the treatment of Clostridium difficile infection
Read More
GIRK activator VU-0466551 shows analgesic effects alone or combined with morphine in pain models
Read More
From bile to biofilm, and back
Read More
Dietary supplement increases brown fat activity
Read More
Vafidemstat improves aggression, other ADHD symptoms in REIMAGINE trial
Read More
Potential Hep B immunotherapeutic target identified
Read More
Momenta Pharmaceuticals presents best-in-class anti-CD38 therapeutic
Read More
LncRNA LINC01614 as a novel biomarker of poor survival in HNSCC
Read More
Biocad CJSC identifies EGFR Leu858Arg/Thr790Met double mutant inhibitors
Read More
Sidecar Therapeutics describes new MAP3K5 inhibitors
Read More
Patient enrollment begins in phase I study of CS1-CAR T therapy for multiple myeloma
Read More
Ubiquitin carboxyl-terminal hydrolase 30 inhibitors discovered at FORMA Therapeutics
Read More
Bristol-Myers Squibb synthesizes new galectin 3 inhibitors
Read More
Janssen initiates first-in-human study of JNJ-67856633
Read More
Zhejiang University patents agents targeting ephrin-A1
Read More
IL-32 identified as a marker for NAFLD diagnosis
Read More
I-Mab begins dosing in phase III study of TJ-202 for multiple myeloma
Read More
FDA approves etanercept biosimilar Eticovo
Read More
FDA approves IND application for TNB-383B
Read More
Orasis Pharmaceuticals' CSF-1 provides improvement in presbyopia
Read More
U.K. MHRA approves CTA for first-in-human study of DYN-101 for centronuclear myopathies
Read More
New report recommends immediate and coordinated action to avert drug-resistance crisis
Read More
Aptinyx reports phase I data for NMDA receptor modulator NYX-458
Read More